Vaishali Sanchorawala, MBBS

Professor, Medicine

Vaishali Sanchorawala
732 Harrison Ave


Expertise includes: AL amyloidosis – clinical trials, treatment; Stem cell transplantation; Myeloma.

Other Positions

  • Director, Amyloidosis Center, Boston University School of Medicine
  • Member, BU-BMC Cancer Center, Boston University


  • Seth G.S. Medical College, MBBS


  • Published on 4/1/2020

    Lerner G, Moradi S, Cohen-Bucay A, Chen H, Sanchorawala V, Gordon CE, Henderson JM. Coincidental crystalline light chain cast nephropathy, light chain proximal tubulopathy, and urine crystallopathy: A case report and review of the literature?. Clin Nephrol. 2020 Apr; 93(4):203-208. PMID: 31907143.

    Read at: PubMed
  • Published on 3/10/2020

    Staron A, Burks EJ, Lee JC, Sarosiek S, Sloan JM, Sanchorawala V. Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis. Blood Adv. 2020 Mar 10; 4(5):880-884. PMID: 32130406.

    Read at: PubMed
  • Published on 2/21/2020

    Lentzsch S, Lagos GG, Comenzo RL, Zonder JA, Osman K, Pan S, Bhutani D, Pregja S, Sanchorawala V, Landau H. Bendamustine With Dexamethasone in Relapsed/Refractory Systemic Light-Chain Amyloidosis: Results of a Phase II Study. J Clin Oncol. 2020 Feb 21; JCO1901721. PMID: 32083996.

    Read at: PubMed
  • Published on 1/24/2020

    Sanchorawala V, Sarosiek S, Schulman A, Mistark M, Migre ME, Cruz R, Sloan JM, Brauneis D, Shelton AC. Safety, Tolerability, and Response Rates of Daratumumab in Relapsed AL Amyloidosis: Results of a Phase II Study. Blood. 2020 Jan 24. PMID: 31978210.

    Read at: PubMed
  • Published on 12/5/2019

    Khor YM, Cuddy S, Harms HJ, Kijewski MF, Park MA, Robertson M, Hyun H, Di Carli MF, Bianchi G, Landau H, Yee A, Sanchorawala V, Ruberg FL, Liao R, Berk J, Falk RH, Dorbala S. Quantitative [18F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis. Eur J Nucl Med Mol Imaging. 2019 Dec 05. PMID: 31807884.

    Read at: PubMed
  • Published on 11/26/2019

    Staron A, Kataria Y, Murray DL, Sloan JM, Sanchorawala V. Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: A zebra without stripes. Am J Hematol. 2020 Feb; 95(2):E45-E48. PMID: 31736101.

    Read at: PubMed
  • Published on 10/23/2019

    Sarosiek S, Sanchorawala V. Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives. J Blood Med. 2019; 10:373-380. PMID: 31695543.

    Read at: PubMed
  • Published on 10/9/2019

    Angel-Korman A, Jaberi A, Sanchorawala V, Havasi A. The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis. Amyloid. 2020 Mar; 27(1):17-24. PMID: 31595786.

    Read at: PubMed
  • Published on 10/4/2019

    Gupta VK, White PS, Brauneis D, Shelton AC, Quillen K, Sanchorawala V, Sarosiek S, Sloan JM. Safety of autologous stem cell transplantation in patients with known Human T-cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients. Am J Hematol. 2019 Dec; 94(12):E317-E319. PMID: 31489689.

    Read at: PubMed
  • Published on 9/13/2019

    Lilleness B, Doros G, Ruberg FL, Sanchorawala V. Establishment of brain natriuretic peptide - based criteria for evaluating cardiac response to treatment in light chain (AL) amyloidosis. Br J Haematol. 2020 Feb; 188(3):424-427. PMID: 31515797.

    Read at: PubMed

View 164 more publications: View full profile at BUMC

View all profiles